Abbott Laboratories - 45 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1980 adjusted for splits and dividends. The latest closing stock price for Abbott Laboratories as of September 02, 2025 is 131.46.
- The all-time high Abbott Laboratories stock closing price was 138.95 on March 03, 2025.
- The Abbott Laboratories 52-week high stock price is 141.23, which is 7.4% above the current share price.
- The Abbott Laboratories 52-week low stock price is 110.86, which is 15.7% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 125.04.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 129.0634 | 111.8260 | 138.9500 | 110.0940 | 131.4600 | 17.90% |
| 2024 | 109.0029 | 106.1630 | 117.6910 | 98.1786 | 111.5000 | 4.82% |
| 2023 | 99.9225 | 103.8250 | 110.1630 | 87.1629 | 106.3760 | 2.26% |
| 2022 | 105.1687 | 129.5640 | 129.5640 | 90.0677 | 104.0240 | -20.68% |
| 2021 | 112.5723 | 100.1260 | 131.8190 | 97.8283 | 131.1480 | 30.53% |
| 2020 | 87.7181 | 78.5522 | 104.9990 | 56.9938 | 100.4750 | 28.04% |
| 2019 | 72.3175 | 61.7632 | 79.8492 | 58.8483 | 78.4709 | 22.08% |
| 2018 | 56.6904 | 51.3052 | 66.0022 | 49.3408 | 64.2781 | 29.06% |
| 2017 | 42.0311 | 33.3057 | 50.1532 | 33.3057 | 49.8042 | 52.03% |
| 2016 | 34.1965 | 35.7159 | 38.3837 | 30.4241 | 32.7598 | -12.32% |
| 2015 | 38.1965 | 36.5806 | 42.3522 | 32.3101 | 37.3632 | 1.87% |
| 2014 | 33.0898 | 30.4643 | 37.7782 | 28.7275 | 36.6783 | 20.08% |
| 2013 | 28.2308 | 25.1294 | 30.8468 | 25.1294 | 30.5440 | 23.96% |
| 2012 | 23.3335 | 20.6622 | 27.1351 | 19.8962 | 24.6409 | 20.30% |
| 2011 | 18.3387 | 16.7891 | 20.5201 | 16.0025 | 20.4837 | 21.78% |
| 2010 | 17.5650 | 18.4966 | 19.2407 | 15.8217 | 16.8207 | -8.27% |
| 2009 | 16.2315 | 17.5980 | 18.9467 | 13.8659 | 18.3370 | 4.57% |
| 2008 | 17.9291 | 17.8737 | 19.5108 | 16.2476 | 17.5356 | -2.49% |
| 2007 | 17.2651 | 15.3152 | 18.8633 | 15.3152 | 17.9826 | 18.04% |
| 2006 | 13.9421 | 12.0446 | 15.3766 | 12.0446 | 15.2339 | 26.86% |
| 2005 | 13.6801 | 13.8854 | 15.0421 | 11.4599 | 12.0080 | -13.48% |
| 2004 | 11.9390 | 11.8198 | 13.9806 | 10.0040 | 13.8794 | 17.80% |
| 2003 | 10.3427 | 9.8905 | 11.9209 | 8.5407 | 11.7819 | 19.27% |
| 2002 | 11.2130 | 13.5043 | 14.0074 | 7.6109 | 9.8781 | -26.73% |
| 2001 | 12.0308 | 11.4416 | 13.7292 | 10.0441 | 13.4825 | 17.08% |
| 2000 | 9.8571 | 8.1709 | 13.2543 | 6.9501 | 11.5158 | 35.84% |
| 1999 | 10.1182 | 11.2142 | 12.2566 | 7.7769 | 8.4773 | -24.79% |
| 1998 | 9.3600 | 7.6418 | 11.4443 | 7.5567 | 11.2717 | 51.86% |
| 1997 | 6.9323 | 5.5826 | 7.7763 | 5.5826 | 7.4222 | 31.97% |
| 1996 | 4.9862 | 4.5289 | 6.2891 | 4.2246 | 5.6241 | 24.56% |
| 1995 | 4.1400 | 3.4746 | 4.8156 | 3.3353 | 4.5153 | 30.45% |
| 1994 | 3.1172 | 2.9862 | 3.5674 | 2.7174 | 3.4613 | 12.97% |
| 1993 | 2.7477 | 3.0632 | 3.1026 | 2.3569 | 3.0638 | 0.02% |
| 1992 | 3.0698 | 3.3267 | 3.3741 | 2.6944 | 3.0632 | -10.09% |
| 1991 | 2.5581 | 2.0978 | 3.4071 | 1.9381 | 3.4071 | 56.10% |
| 1990 | 1.8353 | 1.6437 | 2.2069 | 1.5030 | 2.1827 | 35.24% |
| 1989 | 1.3910 | 1.1067 | 1.6645 | 1.0875 | 1.6140 | 44.70% |
| 1988 | 1.0745 | 1.0998 | 1.1823 | 0.9835 | 1.1154 | 2.21% |
| 1987 | 1.2863 | 1.0513 | 1.4864 | 0.9725 | 1.0913 | 8.07% |
| 1986 | 0.9646 | 0.7381 | 1.1927 | 0.6956 | 1.0098 | 36.05% |
| 1985 | 0.5863 | 0.4293 | 0.7612 | 0.4241 | 0.7422 | 68.22% |
| 1984 | 0.4485 | 0.4730 | 0.5033 | 0.4016 | 0.4412 | -5.16% |
| 1983 | 0.4634 | 0.3724 | 0.5449 | 0.3706 | 0.4652 | 19.28% |
| 1982 | 0.3225 | 0.2718 | 0.4039 | 0.2554 | 0.3900 | 43.49% |
| 1981 | 0.2843 | 0.2862 | 0.3183 | 0.2416 | 0.2718 | -4.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $230.889B | $41.950B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $156.325B | 37.28 |
| Stryker (SYK) | United States | $149.639B | 30.46 |
| EssilorLuxottica (ESLOY) | France | $141.259B | 0.00 |
| Medtronic (MDT) | Ireland | $119.046B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.750B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.937B | 25.13 |
| ResMed (RMD) | United States | $40.192B | 28.75 |
| Agilent Technologies (A) | United States | $35.696B | 23.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.662B | 15.82 |
| Terumo (TRUMY) | Japan | $26.606B | 31.53 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.925B | 80.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.018B | 13.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.402B | 0.00 |
| Baxter (BAX) | United States | $12.681B | 9.80 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.061B | 29.61 |
| Lantheus Holdings (LNTH) | United States | $3.733B | 10.09 |
| Envista Holdings (NVST) | United States | $3.520B | 24.63 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.349B | 14.86 |
| Perrigo (PRGO) | Ireland | $3.266B | 8.16 |
| ICU Medical (ICUI) | United States | $3.151B | 21.45 |
| Haemonetics (HAE) | United States | $2.628B | 11.73 |
| Acuren (TIC) | United States | $2.261B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.213B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.159B | 46.29 |
| QuidelOrtho (QDEL) | United States | $1.948B | 12.26 |
| Green Thumb Industries (GTBIF) | United States | $1.840B | 79.00 |
| AtriCure (ATRC) | United States | $1.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.519B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.503B | 17.74 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.200B | 2505.00 |
| InMode (INMD) | Israel | $0.944B | 8.74 |
| Kestra Medical Technologies (KMTS) | United States | $0.829B | 0.00 |
| Valneva SE (VALN) | France | $0.753B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| SNDL (SNDL) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.52 |
| Evolus (EOLS) | United States | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.479B | 16.50 |
| CeriBell (CBLL) | United States | $0.434B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.379B | 3.36 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.294B | 59.85 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.286B | 21.68 |
| Omeros (OMER) | United States | $0.283B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.242B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.63 |
| FitLife Brands (FTLF) | United States | $0.175B | 0.00 |
| Biote (BTMD) | United States | $0.170B | 5.64 |
| Jushi Holdings (JUSHF) | United States | $0.149B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.78 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 33.68 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 31.08 |
| United-Guardian (UG) | United States | $0.039B | 15.02 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Sharps Technology (STSS) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |